Predicting severity of acute pancreatitis

被引：44

作者：

Rau B.M. ^{[1
]}

机构：

[1] Department of General, Visceral, and Vascular Surgery, University of the Saarland, 66421 Homburg, Saar, Kirrberger Strasse

来源：

Current Gastroenterology Reports | 2007年 / 9卷 / 2期

关键词：

Acute Pancreatitis; Organ Failure; Severe Acute Pancreatitis; Procalcitonin; Activation Peptide;

D O I：

10.1007/s11894-007-0004-5

中图分类号：

学科分类号：

摘要：

Severity stratification is a critical issue in acute pancreatitis that strongly influences diagnostic and therapeutic decision making. According to the widely used Atlanta classification, "severe" disease comprises various local and systemic complications that are associated with an increased risk of mortality. However, results from recent clinical studies indicate that these complications vary in their effect on outcome, and many are not necessarily life threatening on their own. Therefore, "severe," as defined by Atlanta, must be distinguished from "prognostic, aiming at nonsurvival. In the first week after disease onset, pancreatitis-related organ failure is the preferred variable for predicting severity and prognosis because it outweighs morphologic complications. Contrast-enhanced CT and MRI allow for accurate stratification of local severity beyond the first week after symptom onset. Among the biochemical markers, C-reactive protein is still the parameter of choice to assess attack severity, although prognostic estimation is not possible. Other markers, including pancreatic protease activation peptides, interleukins-6 and -8, and polymorphonuclear elastase are useful early indicators of severity. Procalcitonin is one of the most promising single markers for assessment of major complications and prognosis throughout the disease course. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：107 / 115

页数：8

共 65 条

[1] Bradley III E.L., Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992, Arch Surg, 128, pp. 586-590, (1993)
[2] Lankisch P.G., Schirren C.A., Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis, Pancreas, 5, pp. 626-629, (1990)
[3] Martinez J., Johnson C.D., Sanchez-Paya J., Et al., Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: An updated meta-analysis, Pancreatology, 6, pp. 206-209, (2006)
[4] Leppaniemi A., Kemppainen E., Recent advances in the surgical management of necrotizing pancreatitis, Curr Opin Crit Care, 11, pp. 349-352, (2005)
[5] Tao H.Q., Zhang J.X., Zou S.C., Clinical characteristics and management of patients with early acute severe pancreatitis: Experience from a medical center in China, World J Gastroenterol, 10, pp. 919-921, (2004)
[6] De Waele J.J., Hoste E., Blot S.I., Et al., Intra-abdominal hypertension in patients with severe acute pancreatitis, Crit Care, 9, (2005)
[7] Isenmann R., Rau B., Beger H.G., Early severe acute pancreatitis: Characteristics of a new subgroup, Pancreas, 22, pp. 274-278, (2001)
[8] Buter A., Imrie C.W., Carter C.R., Et al., Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis, Br J Surg, 89, pp. 298-302, (2002)
[9] Johnson C.D., Abu-Hilal M., Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis, Gut, 53, pp. 1340-1344, (2004)
[10] Poves Prim I., Fabregat Pous J., Garcia Borobia F.J., Et al., Early onset of organ failure is the best predictor of mortality in acute pancreatitis, Rev Esp Enferm Dig, 96, pp. 705-713, (2004)

← 1 2 3 4 5 6 7 →